{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:49:52Z","timestamp":1788446992977,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,26]],"date-time":"2027-05-26T00:00:00Z","timestamp":1811289600000},"content-version":"am","delay-in-days":420,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sfnmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.siny.2026.101718","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:08:43Z","timestamp":1773130123000},"page":"101718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combined use of erythropoiesis-stimulating agents and transfusion guidelines in NICU infants"],"prefix":"10.1016","volume":"31","author":[{"given":"Robin K.","family":"Ohls","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.siny.2026.101718_bib1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMe0800520","article-title":"New blood, old blood, or no blood","volume":"358","author":"Adamson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.siny.2026.101718_bib2","series-title":"The gift of death: confronting Canada's tainted blood tragedy","author":"Picard","year":"1995"},{"issue":"6","key":"10.1016\/j.siny.2026.101718_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199902113400601","article-title":"A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian critical care trials group","volume":"340","author":"H\u00e9bert","year":"1999","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.siny.2026.101718_bib4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa066240","article-title":"Transfusion strategies for patients in pediatric intensive care units","volume":"356","author":"Lacroix","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.siny.2026.101718_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.95.1.1","article-title":"Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants","volume":"95","author":"Shannon","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2026.101718_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/pch\/7.8.553","article-title":"Red blood cell transfusions in newborn infants: revised guidelines","volume":"7","author":"Faucher","year":"2002","journal-title":"Paediatr Child Heath"},{"key":"10.1016\/j.siny.2026.101718_bib7","series-title":"Semin fetal neonatal med","author":"Patel","year":"2026"},{"key":"10.1016\/j.siny.2026.101718_bib9","series-title":"Semin fetal neonatal med","author":"Josephson","year":"2026"},{"issue":"1","key":"10.1016\/j.siny.2026.101718_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2024.101545","article-title":"A practical guide to reducing\/eliminating red blood cell transfusions in the neonatal intensive care unit","volume":"30","author":"Ohls","year":"2025","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.siny.2026.101718_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/trf.12234","article-title":"Association, among very-low-birthweight neonates, between red blood cell transfusions in the week after birth and severe intraventricular hemorrhage","volume":"54","author":"Christensen","year":"2014","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.siny.2026.101718_bib12","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/j.1537-2995.2011.03081.x","article-title":"Red blood cell transfusion of preterm neonates with a Grade 1 intraventricular hemorrhage is associated with extension to a Grade 3 or 4 hemorrhage","volume":"51","author":"Baer","year":"2011","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.siny.2026.101718_bib13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/s41372-025-02519-3","article-title":"The nucleated red blood cell count at birth, the volume of red cell transfusions received, and the risk of developing retinopathy of prematurity","volume":"45","author":"Zeiler","year":"2025","journal-title":"J Perinatol"},{"key":"10.1016\/j.siny.2026.101718_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103426","article-title":"Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial","volume":"87","author":"Teofili","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.siny.2026.101718_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9643","article-title":"Timing of red blood cell transfusions and occurrence of necrotizing enterocolitis: a secondary analysis of a randomized clinical trial","volume":"7","author":"Salas","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.siny.2026.101718_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2025.101615","article-title":"Severe anemia predisposes very premature infants to transfusion-associated necrotizing enterocolitis","volume":"30","author":"Maheshwari","year":"2025","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.siny.2026.101718_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2023.113836","article-title":"Can red blood cell and platelet transfusions have a pathogenic role in bronchopulmonary dysplasia?","volume":"265","author":"Bahr","year":"2024","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.siny.2026.101718_bib18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41372-024-02135-7","article-title":"The number of blood transfusions received and the incidence and severity of chronic lung disease among NICU patients born >31 weeks gestation","volume":"45","author":"Bahr","year":"2025","journal-title":"J Perinatol"},{"issue":"6","key":"10.1016\/j.siny.2026.101718_bib19","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41372-021-00997-9","article-title":"Effect of blood transfusions onTx and development","volume":"41","author":"Shah","year":"2021","journal-title":"J Perinatol"},{"issue":"1","key":"10.1016\/j.siny.2026.101718_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41390-020-01273-w","article-title":"Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT trial: a randomized clinical trial","volume":"90","author":"Vu","year":"2021","journal-title":"Pediatr Res"},{"issue":"3-4","key":"10.1016\/j.siny.2026.101718_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02934992","article-title":"Physiologic and molecular biology of erythropoietin","volume":"3","author":"Erslev","year":"1986","journal-title":"J Med Oncol Tumor Pharmacother"},{"issue":"8","key":"10.1016\/j.siny.2026.101718_bib22","first-page":"1097","article-title":"Darbepoetin alfa. Amgen","volume":"2","author":"Locatelli","year":"2001","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.siny.2026.101718_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3476(05)82552-1","article-title":"Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants","volume":"121","author":"Carnielli","year":"1992","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.siny.2026.101718_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.semperi.2008.10.006","article-title":"Current controversies in the management of the anemia of prematurity","volume":"33","author":"Bishara","year":"2009","journal-title":"Semin Perinatol"},{"issue":"1","key":"10.1016\/j.siny.2026.101718_bib25","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1542\/peds.2013-0143","article-title":"A randomize, masked, placebo-controlled study of darbepoetin alfa in preterm infants","volume":"132","author":"Ohls","year":"2013","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.siny.2026.101718_bib26","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1542\/peds.2013-4307","article-title":"Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo","volume":"133","author":"Ohls","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2026.101718_bib27","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3859","article-title":"Preschool assessment of preterm infants treated with darbepoetin and erythropoietin","volume":"137","author":"Ohls","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.siny.2026.101718_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/1573396319666221219114704","article-title":"Longitudinal assessment of preterm infants treated with erythropoiesis stimulating agents","volume":"19","author":"Ohls","year":"2023","journal-title":"Curr Pediatr Rev"},{"issue":"11","key":"10.1016\/j.siny.2026.101718_bib29","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/neo.20-11-e622","article-title":"Update on erythropoiesis-stimulating agents administered to neonates for neuroprotection","volume":"20","author":"Maxwell","year":"2019","journal-title":"NeoReviews"},{"issue":"8","key":"10.1016\/j.siny.2026.101718_bib30","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamapediatrics.2025.0807","article-title":"Darbepoetin, red cell mass, and neuroprotection in preterm infants: a randomized clinical trial","volume":"179","author":"Ohls","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.siny.2026.101718_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/jp.2014.171","article-title":"Why do four NICUs using identical RBC transfusion guidelines have different gestational age-adjusted RBC transfusion rates?","volume":"35","author":"Henry","year":"2015","journal-title":"J Perinatol"},{"issue":"3","key":"10.1016\/j.siny.2026.101718_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004863.pub2","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"19","author":"Ohlsson","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.siny.2026.101718_bib33","article-title":"Late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","author":"Aher","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.siny.2026.101718_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004863.pub3","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","author":"Ohlsson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.siny.2026.101718_bib35","article-title":"Early erythropoiesis-stimulating agents in preterm or low birth weight infants","volume":"2","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.siny.2026.101718_bib36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41372-024-02047-6","article-title":"Treating preterm infants with erythropoietin does not increase the risk of retinopathy of prematurity","volume":"45","author":"Bahr","year":"2025","journal-title":"J Perinatol"},{"issue":"1","key":"10.1016\/j.siny.2026.101718_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41372-025-02345-7","article-title":"Three studies needed to inform the design of the U-BET (umbilical cord blood for extremely low-gestational-age transfusions) clinical trial","volume":"46","author":"Bahr","year":"2026","journal-title":"J Perinatol"},{"key":"10.1016\/j.siny.2026.101718_bib38","doi-asserted-by":"crossref","first-page":"28983","DOI":"10.1074\/jbc.274.41.28983","article-title":"Biochemical characterization of S-Nitroso-hemoglobin","volume":"274","author":"Woltz","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.siny.2026.101718_bib39","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jpeds.2011.10.026","article-title":"A randomized, masked study of weekly erythropoietin dosing in preterm infants","volume":"160","author":"Ohls","year":"2012","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.siny.2026.101718_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41372-025-02247-8","article-title":"A prospective randomized pilot trial comparing weekly vs. biweekly Darbepoetin administration to preterm infants","volume":"45","author":"Bahr","year":"2025","journal-title":"J Perinatol"},{"issue":"8","key":"10.1016\/j.siny.2026.101718_bib41","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jpedsurg.2008.10.112","article-title":"Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery","volume":"44","author":"Bierer","year":"2009","journal-title":"J Pediatr Surg"},{"issue":"12","key":"10.1016\/j.siny.2026.101718_bib42","doi-asserted-by":"crossref","first-page":"e976","DOI":"10.1016\/S2352-3026(23)00285-5","article-title":"Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial","volume":"10","author":"Ree","year":"2023","journal-title":"Lancet Haematol"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X2600020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X2600020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T19:54:32Z","timestamp":1779825272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X2600020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1744165X2600020X"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2026.101718","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined use of erythropoiesis-stimulating agents and transfusion guidelines in NICU infants","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2026.101718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101718"}}